Press releases
- AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
- AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
- AngioDynamics Receives 510(k) Clearance for AlphaVac F18⁸⁵ System in Treatment of PE
- AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
- AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
- AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
More ▼
Key statistics
On Friday, AngioDynamics Inc (UG2:FRA) closed at 5.45, 14.50% above the 52 week low of 4.76 set on Mar 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.80 |
---|---|
High | 5.80 |
Low | 5.45 |
Bid | 5.45 |
Offer | 5.65 |
Previous close | 5.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | 40.05m |
Free float | 38.05m |
P/E (TTM) | -- |
Market cap | 241.93m USD |
EPS (TTM) | -4.78 USD |
Data delayed at least 15 minutes, as of May 17 2024 20:55 BST.
More ▼